Huanglian Jiedu Decoction Alleviates Metabolic-Associated Fatty Liver Disease in vivo and in vitro via IRE1α/XBP1s Signaling PathwayOA
Huanglian Jiedu Decoction Alleviates Metabolic-Associated Fatty Liver Disease in vivo and in vitro via IRE1α/XBP1s Signaling Pathway
ZHENG An-ni;LIN Meng-yu;ZHENG Ji-xian;XU Qiu-ling;LIU Tao
Department of Traditional Chinese Medicine,the First Affiliated Hospital of Hainan Medical University,Haikou(571199),China||College of Traditional Chinese Medicine,Hainan Medical University,Haikou(571199),ChinaDepartment of Traditional Chinese Medicine,the First Affiliated Hospital of Hainan Medical University,Haikou(571199),China||College of Traditional Chinese Medicine,Hainan Medical University,Haikou(571199),ChinaCollege of Traditional Chinese Medicine,Hainan Medical University,Haikou(571199),ChinaDepartment of Traditional Chinese Medicine,the First Affiliated Hospital of Hainan Medical University,Haikou(571199),China||College of Traditional Chinese Medicine,Hainan Medical University,Haikou(571199),ChinaDepartment of Traditional Chinese Medicine,the First Affiliated Hospital of Hainan Medical University,Haikou(571199),China||College of Traditional Chinese Medicine,Hainan Medical University,Haikou(571199),China
metabolic-associated fatty liver diseaseHuanglian Jiedu Decoctioninositol-requiring enzyme 1alpha/X-box-binding protein-1 spliced signaling pathwayChinese medicine
metabolic-associated fatty liver diseaseHuanglian Jiedu Decoctioninositol-requiring enzyme 1alpha/X-box-binding protein-1 spliced signaling pathwayChinese medicine
《中国结合医学杂志（英文版）》 2026 (3)
232-240,9
Supported by the Youth Qi Huang Scholar Project of State Administration of Traditional Chinese Medicine(No.[2022]256 of the National Traditional Chinese Medicine Human Resource Education),the Natural Science Foundation of Hainan Province(No.821RC579)and the National Natural Science Foundation of China(No.81760795)
评论